One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database

Current Medical Research and Opinion
Joseph MenzinMark Friedman

Abstract

Acute coronary syndromes (ACS) are life-threatening disorders requiring intensive medical management or invasive cardiovascular procedures. Limited data exist on the costs and resource utilization associated with ACS. This retrospective single-cohort study analyzed administrative claims data from employer-sponsored plans for patients with an ACS hospitalization in 2001-2002. A 1-year follow-up period was used, and patients who were under age 35 or had an ACS diagnosis in the 12 months before the hospitalization were excluded. Costs were reported in 2005 US dollars. We identified 16,321 patients hospitalized for ACS during the study period. Mean (+/- SD) age was 55.6 (+/- 6.7) years, 66.7% were male, and 46.3% underwent a revascularization procedure during their initial hospitalization. Mean length of stay for the initial hospitalization was 4.6 days (median: 3.0; IQR: 2.0-5.0), and per-patient expenditures averaged $22,921 (median: $13,960; IQR: $6839-28 588). During the follow-up period, 21% of patients were rehospitalized for ischemic heart disease (IHD), and the cost of rehospitalization averaged $28,637. Additionally, in the year following the inpatient admission, 50% of patients were prescribed antiplatelet or anticoagulan...Continue Reading

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Jan 28, 2004·Circulation·Philippe Gabriel StegUNKNOWN Global Registry of Acute Coronary Events Investigators
May 6, 2005·Journal of Managed Care Pharmacy : JMCP·Lida R Etemad, Patrick L McCollam
Feb 3, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Douglas L JenningsJames S Kalus
Oct 19, 2006·International Journal of Cardiology·Enrique P GurfinkelUNKNOWN GRACE Investigators
Dec 30, 2006·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Mar 5, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·J ZeidlerJ-M Graf von der Schulenburg
Jul 11, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Nikos ManiadakisJohn Kyriopoulos
May 18, 2013·Journal of General Internal Medicine·Michael PignoneMark J Pletcher
Oct 20, 2011·Circulation. Cardiovascular Quality and Outcomes·Rebecca L ReeseRobert M Carney
Aug 9, 2013·BMC Cardiovascular Disorders·Jinhyun KimAeree Sohn
Feb 15, 2011·BMC Health Services Research·Zhenxiang Zhao, Melissa Winget
Dec 9, 2009·Current Medical Research and Opinion·Karina BerensonJohn Corbelli
Dec 29, 2015·Current Medical Research and Opinion·David M KernNiklas Hammar
May 25, 2011·International Journal of Cardiology·Lorenzo G MantovaniGiancarlo Cesana
Oct 12, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Tomás Villanueva
Feb 6, 2014·Fundamental & Clinical Pharmacology·Dan AtarFreek W A Verheugt
Jan 13, 2015·Journal of the American Association of Nurse Practitioners·Susan D Housholder-HughesMelvyn Rubenfire
Sep 25, 2014·Journal of Clinical Pharmacy and Therapeutics·W H OlsonS M Lynch
Jan 18, 2015·European Journal of Epidemiology·Taulant MukaOscar H Franco
Nov 22, 2012·The American Journal of Cardiology·William E BodenDominick J Angiolillo
Apr 18, 2015·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·R J G Peters
Sep 21, 2013·Journal of Intensive Care Medicine·Nader MakkiSaket Girotra
Nov 23, 2012·Journal of Pharmacy Practice·Paul P Dobesh, Julie H Oestreich
Aug 5, 2017·European Heart Journal. Acute Cardiovascular Care·Stuart J PocockHéctor Bueno
Jul 31, 2018·Journal of Managed Care & Specialty Pharmacy·Kibum KimSurrey M Walton
Feb 4, 2010·Circulation·Neal B Patel, Gary J Balady
May 19, 2011·Circulation. Cardiovascular Imaging·Subha V Raman, Giuseppe Ambrosio
Aug 28, 2010·Journal of Occupational and Environmental Medicine·Kathleen LangJoseph Menzin
Sep 12, 2012·American Journal of Therapeutics·Philip J Dougherty, Rohit R Arora

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.